Severe COVID-19 and chronic kidney disease: bidirectional mendelian randomization study

Area of Science:

• Genetics
• Epidemiology
• Nephrology

Background:

• Observational studies suggest an association between severe COVID-19 and chronic kidney disease (CKD).
• The causal relationship between CKD and severe COVID-19 remains unclear.
• Investigating genetic links can clarify causality and inform personalized risk assessment.

Purpose of the Study:

• To determine if genetically predicted CKD is associated with the risk of critical COVID-19.
• To explore potential genetic mechanisms underlying this association.
• To provide evidence for targeted interventions for individuals with CKD.

Main Methods:

• Bidirectional Mendelian randomization analysis using GWAS data from European ancestry.
• Instrumental variables (SNPs) for CKD and critical COVID-19.
• Inverse-variance weighted estimate, MR-Egger regression, weighted mode, and weighted medians were employed.

Main Results:

• A significant causal association was found between genetically predicted CKD and critical COVID-19 (OR=1.28, P=0.018).
• No significant causal association was observed between genetically predicted critical COVID-19 and CKD (OR=1.03, P=0.395).

Conclusions:

• Evidence supports a causal relationship where CKD increases the risk of severe COVID-19 in European populations.
• Highlights the need for enhanced monitoring and specialized care for CKD patients regarding COVID-19.
• Findings may guide personalized risk assessment and interventions for COVID-19 in CKD patients.